ACURASYS
2010
Neuromuscular Blockers in Early ARDS
In 340 patients with severe ARDS within 48 hours, 48-hour cisatracurium infusion reduced 90-day mortality compared with placebo.
Result
Efficacy: Adjusted 90-day mortalityAdjusted HR 0.68 (95% CI 0.48-0.98) · P = 0.04
Below 1 favours 48-hour cisatracurium infusion, above 1 favours placebo.
- Subtopic
- Neuromuscular blockade
- Design
- Multicentre RCT, France
- Relevance
- Supporting: context rather than must-know.
- Source
- Papazian L, et al. N Engl J Med. 2010;363(12):1107-1116.doi 10.1056/NEJMoa1005372
Discussion & critique
Mortality benefit not replicated in ROSE; routine NMB no longer recommended in modern, lightly sedated ARDS.